---
title: "Philips Reports Strong Order Intake Despite Uncertain Macro Environment"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285408177.md"
description: "Philips reported a 6% increase in order intake and a 4% rise in comparable sales for Q1 2026, with adjusted earnings per share of 27 cents, surpassing expectations. Despite a challenging macro environment, the healthcare technology company showed growth across all segments, particularly in Personal Health. The stock rose 2.72% to $27.17, although technical indicators suggest mixed near-term momentum. Philips maintains its 2026 outlook with expected sales growth of 3%-4.5% and an adjusted EBITA margin of 12.5%-13.0%."
datetime: "2026-05-06T15:55:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285408177.md)
  - [en](https://longbridge.com/en/news/285408177.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285408177.md)
---

# Philips Reports Strong Order Intake Despite Uncertain Macro Environment

**Koninklijke Philips N.V.** (NYSE:PHG) shares were trading higher on Wednesday as the company reported strong order intake and comparable sales growth in its recent first quarter 2026 performance.

## Strong Order Intake And Sales Growth Support Momentum

The positive momentum comes following an announcement that highlighted a 6% increase in order intake and a 4% rise in comparable sales, reflecting disciplined execution in a challenging macro environment, particularly in North America and Europe.

The healthcare technology company reported adjusted earnings of 27 cents per share, beating the consensus of 23 cents.

Sales reached $4.57 billion (3.91 billion euros), slightly below the consensus of $4.60 billion.

Comparable sales increased 4%, with growth across all segments led by Personal Health.

**Read Also: BioNTech Slides As Vaccine Sales Drop, Restructuring Plan Takes Shape**

Comparable order intake increased 6%, driven by growth in both Diagnosis & Treatment and Connected Care, and continued strong performance in North America and the International Region.

## Segment Performance Driven By Personal Health And Diagnosis Units

**Diagnosis & Treatment** sales reached 1.85 billion euros. Adjusted EBITA margin was 9.8%, up 30 basis points, mainly driven by higher sales and productivity, partly offset by higher tariffs and cost inflation.

Comparable sales increased by 2%, reflecting high single-digit growth in image-guided therapy, partly offset by a low single-digit decline in precision diagnosis.

**Connected Care** revenues were 1.06 billion euros. Adjusted EBITA margin declined 60 basis points to 2.9%, mainly due to the impact of higher tariffs and cost inflation, partly offset by productivity and higher sales.

Comparable sales increased by 3%, mainly driven by mid-single-digit growth in Monitoring.

**Personal Health** sales were 818 million euros, reflecting comparable sales increased 9%. Adjusted EBITA margin increased 60 basis points to 15.8%, driven by higher sales and productivity, and partly offset by higher tariffs, advertising and promotions spend, and cost inflation.

Philips reiterates 2026 outlook with comparable sales growth of 3%-4.5%, Adjusted EBITA Margin of 12.5%-13.0%, and free cash flow target of 1.3-1.5 billion euros.

## PHG Technical Analysis: Key Support, Resistance And Momentum

The stock’s current price of $27.04 is 2.9% below its 20-day simple moving average (SMA) of $27.80 and 4.4% below the 50-day SMA of $28.24.

The moving average convergence divergence (MACD) is currently below its signal line, suggesting fading momentum, which indicates that upside pressure may be cooling unless the stock can reclaim that baseline.

**Key Resistance**: $28.50 — a nearby level where rebounds can stall, aligning with the 50-day SMA.

**Key Support**: $26.50 — a nearby level where buyers previously stepped in, reflecting previous support zones.

**PHG Price Action:** Koninklijke Philips shares were up 2.72% at $27.17 at the time of publication on Wednesday, according to Benzinga Pro data.

_Photo by Mats Wiklund via Shutterstock_

**Read Also: Micron Stock Climbs On Cramer's Bullish Take: AI Storage Demand Secular, Not Cyclical**

### Related Stocks

- [PHG.US](https://longbridge.com/en/quote/PHG.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [RYLPF.US](https://longbridge.com/en/quote/RYLPF.US.md)
- [BNTX.US](https://longbridge.com/en/quote/BNTX.US.md)
- [MU.US](https://longbridge.com/en/quote/MU.US.md)

## Related News & Research

- [Edwards Lifesciences CVP, Strategy/Corp Development Sold Shares Worth Over $1.4M](https://longbridge.com/en/news/286822028.md)
- [embecta Completes Acquisition of Owen Mumford Holdings Limited](https://longbridge.com/en/news/286571686.md)
- [Coherent Corp. Rocked by Major Insider Stock Move From Company Director](https://longbridge.com/en/news/286343834.md)
- [EMERGING MARKETS-LatAm assets set for weekly losses on political uncertainty, inflation concerns](https://longbridge.com/en/news/286612207.md)
- [Stryker Buys Amplitude Vascular Systems For Upto $835 Mln To Expand Vascular Treatment Business](https://longbridge.com/en/news/286889480.md)